CLINICAL TRIALS AND OBSERVATIONS A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605
نویسندگان
چکیده
1Leukemia Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; 2Southwest Oncology Group (SWOG) Study Statistical Center, Seattle, WA; 3H. Lee Moffitt Cancer Center, Tampa, FL; 4Seattle Cancer Care Alliance, Seattle, WA; 5University of Rochester, Rochester, NY; 6University of Washington, Seattle, WA; 7University of New Mexico Cancer Center, Albuquerque, NM; and 8Fred Hutchinson Cancer Research Center, Seattle, WA
منابع مشابه
CLINICAL TRIALS AND OBSERVATIONS Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome
The erythropoietic effects of lenalidomide are cytokine dependent, suggesting that the erythroid hematologic improvement (HI-E) rate may be augmented by combined treatment (CT) with recombinant human erythropoietin (rhu-EPO) in myelodysplastic syndrome (MDS). In the present study, we explored the benefits of CT and the relationship between lenalidomide pharmacokinetics and hematologic toxicity ...
متن کاملCLINICAL TRIALS AND OBSERVATIONS A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
Older patients with acute myeloid leukemia (AML) have limited treatment options and a poor prognosis, thereby warranting novel therapeutic strategies. We evaluated the efficacy of lenalidomide as frontline therapy for older AML patients. In this phase 2 study, patients 60 years of age or older with untreated AML received highdose (HD) lenalidomide at 50 mg daily for up to 2 28-day cycles. If pa...
متن کاملRegular Article CLINICAL TRIALS AND OBSERVATIONS A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
Fred Hutchinson Cancer Research Center, Seattle, WA; Southwest Oncology Group Statistical Center, Seattle, WA; City of Hope Medical Center, Duarte, CA; University of New Mexico, Albuquerque, NM; Vancouver General Hospital, Vancouver, BC, Canada; University of Toronto, Toronto, Ontario, Canada; University of Chicago, Chicago, IL; University of Michigan, Ann Arbor, MI; Loyola University Medical C...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Impact of trisomy 8 ( 8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study
The prognostic impact of trisomy 8, alone or with other clonal aberrations, was evaluated in 849 patients with previously untreated acute myeloid leukemia (AML) who were registered to 5 Southwest Oncology Group trials. At presentation, 108 (12.7%) patients had 8 in their karyotypes, including 43 (5.1%) patients with 8 as the sole aberration; 307 (36.2%) were normal, and 434 (51.1%) had other cy...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study
Complete remission and long-term survival rates are low for older adults treated for acute myeloid leukemia (AML). Because of favorable phase 2 data using mitoxantrone and etoposide, we conducted a phase 3 study (SWOG-9333) in which patients over 55 years of age with previously untreated AML were randomized to receive mitoxantrone (10 mg/m2 per day 5) and etoposide (100 mg/m2 per day 5) [ME], o...
متن کامل